 | Fiscal NoteS.B. 261 2026 General Session Pharmacy Practice Amendments by Vickers, Evan J. |  |
| Ongoing | One-time | Total | |
|---|---|---|---|
| Net GF/ITF/USF (rev.-exp.) | $0 | $(9,400) | $(9,400) |
| Revenues | FY2026 | FY2027 | FY2028 |
| Commerce Service Account, One-time | $0 | $9,400 | $0 |
| General Fund, One-time | $0 | $(9,400) | $0 |
| Total Revenues | $0 | $0 | $0 |
Enactment of this legislation could decrease the year-end transfer from the Commerce Service Account to the General Fund by $9,400 one-time in FY 2027 due to the expenditures listed below.
| Expenditures | FY2026 | FY2027 | FY2028 |
| Commerce Service Account, One-time | $0 | $9,400 | $0 |
| Total Expenditures | $0 | $9,400 | $0 |
Enactment of this legislation could increase costs to the Department of Commerce by $9,400 one-time from the Commerce Service Account in FY 2027 for staff support to vet, select, and implement an electronic tracking system for pseudoephedrine.
| FY2026 | FY2027 | FY2028 | |
| Net All Funds (rev-exp) | $0 | $(9,400) | $0 |
Enactment of this legislation likely will not result in direct, measurable costs for local governments.
Enactment of this legislation likely will not result in direct expenditures from tax or fee changes for Utah residents and businesses.
Enactment of this legislation could result in a small reduction in the regulatory burden for Utah residents or businesses.
This bill creates a new program or significantly expands an existing program.
For a list of questions lawmakers might ask to improve accountability for the proposed
program, please see:
https://budget.utah.gov/newprogram